Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742443 · ClinicalTrials.gov registry record · Phase 3
Juvista in Scar Revision Surgery of Disfiguring Scars
A Phase 3 study, sponsored by Renovo.
- Completed
- Registry status
- Phase 3
- Development phase
- 350
- Enrollment target
NCT00742443: Completed Phase 3 study, sponsored by Renovo.
NCT00742443 is a Phase 3 study that has completed, run by Renovo. The registered enrollment target is 350 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00742443, a Phase 3 study, has completed, sponsored by Renovo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 350 participants
- Enrollment target
Study Summary
This trial is to determine whether Juvista can prevent scar formation or improve the appearance of scars following scar revision surgery. The trial will involve comparing Juvista to placebo.
Interventions
- DRUG Juvista (avotermin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
What the finished NCT00742443 record still lists
NCT00742443 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Juvista (avotermin) is the first listed.
NCT00742443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00742443 about?
NCT00742443 is a clinical study titled "Juvista in Scar Revision Surgery of Disfiguring Scars". This trial is to determine whether Juvista can prevent scar formation or improve the appearance of scars following scar revision surgery. The trial will involve comparing Juvista to placebo.
What is the current status of trial NCT00742443?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 350 participants. The study started on 2008-12. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00742443?
The interventions under investigation include: Juvista (avotermin) (DRUG).
Who is sponsoring clinical trial NCT00742443?
This trial is sponsored by Renovo, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00742443's enrollment target sits among peer trials
350 1034th of 2000 higher than 956 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia